Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is an independent risk factor for neonatal morbidity and may be more sensitive than birth weight percentile as a marker of undernutrition. Further studies are needed to determine whether BF% should be used as a screening tool for undernutrition in high-risk populations. Clinicians should be aware of this potential marker of undernutrition when assessing neonatal morbidity. Increased awareness of BF% could help identify undernutrition early in high-risk populations. Further work is required to determine whether BF% can be used as a reliable screening test for undernutrition. The use of BF% as a screening tool would need to be evaluated in future studies. It remains unclear whether BF% is superior to birth weight percentile or other markers of undernutrition. Future research is necessary to determine if BF% should become part of routine screening protocols in the clinical setting. Further research is required to evaluate whether BF% could serve as a useful adjunct to existing measures of undernutrition. Further research is warranted to determine if BF% is a valuable addition to the current array of tools used to assess undernutrition in the neonate.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.4
Reasoning:
The assistant correctly notes that low BF% is an independent risk factor and that BF% may be a more sensitive marker than birth weight percentiles. However the reply is overly repetitive, vague, and hedges unnecessarily — it fails to state the study's main finding clearly (that in this population BF% was more closely associated with neonatal morbidity than birth weight percentiles and can identify appropriately grown but undernourished neonates), and it gives no supporting data or concrete conclusion. Overall the response is partially correct but incomplete and poorly communicated.

conciseness: 0.3
Reasoning:
The response is repetitive and wordy, failing to give a concise, definitive summary of the study findings. It briefly states BF% "may be more sensitive" but then repeatedly calls for further research without succinctly linking the study's stronger association (higher OR for BF%) to the conclusion. It neither cites the effect sizes nor clearly answers the question in one clear sentence.

relevance: 0.6
Reasoning:
The assistant’s reply is partially relevant: it states that low BF% is an independent risk factor and "may be more sensitive" than birth weight percentiles, which addresses the question. However, it fails to cite or quote the study data (no odds ratios, prevalence, or the statement that BF% was more closely associated with morbidity), and it becomes repetitive and internally contradictory by later saying it is "unclear whether BF% is superior." Overall the answer answers the question in a vague, hedged way without grounding in the provided context or using the study’s specific findings.

coherence: 0.5
Reasoning:
The response is generally coherent and stays on topic, but it is repetitive and offers little structure or concrete evidence from the study. It begins with a clear claim (low BF% is an independent risk factor and may be more sensitive than birth weight percentile) but then repeatedly hedges that further research is needed without summarizing the study's findings or giving a concise conclusion. Overall it answers the question in a cautious way but lacks clarity, specificity, and conciseness.

helpfulness: 0.4
Reasoning:
This response correctly notes that low BF% is an independent risk factor and suggests it may be more sensitive than birth weight percentiles, but it is overly repetitive, hedges excessively, and fails to cite the study's key quantitative findings (stronger OR for BF% vs birth weight percentile, and the count/rate of low BF% cases). It does not give a clear, concise answer to the question (yes/no with supporting evidence) and adds little actionable interpretation.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: In our experience, ischemic Charcot neuroarthropathy should be considered as a separate disease entity from the classic Charcot neuroarthropathy, which is characterized by an association with peripheral arterial occlusive disease. Our results show that ischemic Charcot neuroarthropathy requires different management strategies than the classic Charcot neuroarthropathy. Patients affected by ischemic Charcot neuroarthropathy should be treated promptly and aggressively. We recommend that they undergo early endovascular revascularization, which should be combined with surgical debridement and orthopedic correction. The aim of this approach is to prevent further tissue damage and to avoid the need for amputation. Our preliminary results suggest that ischemic Charcot neuroarthropathy can be successfully treated with this multimodality approach. Further studies are needed to confirm these results.
Therefore, we recommend that clinicians consider the possibility of ischemic Charcot neuroarthropathy when treating diabetic patients with critical limb ischemia. Moreover, we suggest that the treatment of ischemic Charcot neuroarthropathy be based on the principles of conservative treatment of the underlying peripheral vascular disease. This may include endovascular revascularization, debridement and orthopedic correction. However, further studies are necessary to confirm these results.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.8
Reasoning:
The assistant's answer correctly emphasizes that ischemic (neuroischemic) Charcot foot requires a different management approach than purely neuropathic Charcot disease — specifically, that revascularization (typically endovascular), combined with surgical debridement and orthopedic reconstruction, is important to support healing and avoid major amputation. This matches the ground-truth conclusion that revascularization is necessary to enable limb and foot salvage. The response is somewhat repetitive and slightly overstates the issue by calling ischemic Charcot a wholly separate "disease entity" rather than a clinically distinct ischemic variant that requires additional vascular treatment; otherwise the clinical recommendation is accurate and appropriately cautious about needing further studies.

conciseness: 0.5
Reasoning:
The assistant’s reply correctly answers the question (saying ischemic Charcot foot is a distinct entity that requires different, more aggressive treatment including revascularization plus surgical/orthopedic care). However the response is repetitive and wordy (repeating recommendations and "further studies needed" multiple times) and could be much more concise—one or two clear sentences would suffice. 

relevance: 0.8
Reasoning:
The assistant's reply directly addresses the question by stating that ischemic Charcot neuroarthropathy should be considered a distinct entity requiring different management, and it recommends early endovascular revascularization combined with surgical debridement and orthopedic correction — which matches the treatments described in the context. However, the answer does not cite the study's concrete results (for example the 90% limb salvage rate or mean healing time) or quote wording from the provided text, and it is somewhat repetitive. Overall the response is relevant and aligned with the context but could be improved by including specific outcome data from the study.

coherence: 0.7
Reasoning:
The response is generally coherent and well structured: it directly answers the question by distinguishing ischemic Charcot neuroarthropathy from classic Charcot disease and recommending a different, more aggressive management strategy (early endovascular revascularization combined with surgical debridement and orthopedic correction). Strengths include clear recommendations that align with the study context and a call for further research. Weaknesses are some redundancy (repeating the need for further studies), a minor inconsistency in wording (calling the approach “conservative treatment” of vascular disease while recommending early revascularization), and a lack of specific outcome details from the data presented.

helpfulness: 0.8
Reasoning:
The assistant's reply is generally helpful and directly answers the question: it correctly identifies ischemic Charcot neuroarthropathy as requiring a different, more aggressive management strategy (early endovascular revascularization combined with surgical debridement and orthopedic correction) and emphasizes limb-salvage goals and the need for further study. Strengths: clear, actionable recommendation consistent with the study context and focus on revascularization to enable surgical/orthopedic treatment. Weaknesses: slightly repetitive, somewhat strong wording ("separate disease entity") without nuance, and it omits concrete outcome figures (limb salvage rate, healing time) that were present in the data and would strengthen the recommendation.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: This study suggests that radical hysterectomy is unnecessary for patients with endometrial cancer suspected cervical involvement. This is based on the fact that there is no difference in clinical outcome between radical hysterectomy and mild or simple hysterectomy for patients with suspected cervical involvement. Although radical hysterectomy is recommended for patients with endometrial cancer with suspected cervical involvement, this study did not show any benefit in terms of long-term survival when compared to other types of hysterectomies. Moreover, radical hysterectomy might be associated with increased morbidity such as prolonged operative time, blood loss and postoperative complications. Therefore, we could suggest that radical hysterectomy should be reserved only for those patients who have poor prognosis. Further studies are needed to confirm these findings.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.6
Reasoning:
The assistant's reply correctly summarizes the key findings: the study found no survival benefit from radical hysterectomy (RH) versus modified radical or simple hysterectomy, and RH was associated with greater perioperative morbidity (longer operative time, more transfusions/complications). However, the answer has two problems: it uses "mild" instead of "modified" hysterectomy (terminology error), and it makes an unsupported clinical recommendation ("RH should be reserved only for those patients who have poor prognosis") that goes beyond the study's retrospective findings and the authors' cautious conclusion that surgical strategy needs prospective evaluation. Overall the summary is mostly accurate but includes one wording mistake and one unwarranted inference.

conciseness: 0.7
Reasoning:
The assistant's reply is concise and largely captures the study's main findings (no survival benefit from radical hysterectomy and higher morbidity), but it contains a minor terminology error ("mild" instead of "modified" hysterectomy) and slightly overstates a clinical recommendation ("should be reserved only for those patients who have poor prognosis") that the retrospective data do not directly support. Overall clear and brief but with small inaccuracies and an unwarranted recommendation.

relevance: 0.7
Reasoning:
Explanation: The assistant's reply is largely relevant — it summarizes the study's main findings (no survival benefit from radical hysterectomy and higher morbidity) and answers the question about whether RH is needed. However, it contains minor inaccuracies and overstatements: it calls modified radical hysterectomy "mild" (terminology error), paraphrases higher transfusion rates as "blood loss" and "blood loss and postoperative complications" rather than noting the study specifically reported higher transfusion rates and urinary tract dysfunction, and it goes beyond the study by recommending RH be "reserved only for those patients who have poor prognosis" (the study instead called for further prospective evaluation). These issues slightly reduce fidelity to the provided context.

coherence: 0.8
Reasoning:
The assistant's reply is clear, concise, and well organized: it states the main conclusion (no survival benefit from radical hysterectomy), notes the increased morbidity with RH, and calls for further study. However, it includes a mildly speculative recommendation ("should be reserved only for those patients who have poor prognosis") that is not supported by the presented study, and it uses slightly imprecise wording ("mild" hysterectomy; generalizes adverse events as "blood loss and postoperative complications" rather than the reported transfusion rates and urinary dysfunction). Overall coherent and readable but with small inaccuracies and an unsupported clinical recommendation.

helpfulness: 0.7
Reasoning:
The assistant's reply correctly captures the main study findings: no survival benefit from radical hysterectomy (RH) versus modified radical or simple hysterectomy, and higher morbidity with RH (longer operative time and more complications). It is concise and generally helpful. However, it has minor inaccuracies and overstatements: it uses "mild" instead of "modified radical" hysterectomy, generically cites "blood loss" rather than the reported higher transfusion rates and specifically increased severe urinary tract dysfunction, and it makes an unsupported clinical recommendation (that RH "should be reserved only for those patients who have poor prognosis") that goes beyond the retrospective study’s conclusions. The answer also omits explicit mention that type of hysterectomy was not an independent prognostic factor for local recurrence-free survival, PFS, and OS. Overall, a good summary but with small factual slips and one unwarranted recommendation.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Patients who require readmission after PD are at risk of developing complications that may be related to the underlying disease or its treatment. Pancreatic fistula, which occurs in 15 % of cases, is an independent risk factor for readmission. Multivisceral resection during PD increases the risk of readmission threefold. Other predisposing factors include prolonged initial hospital stay, increased number of ICU admissions, and absence of postoperative prophylactic antibiotics. Prolonged length of stay and ICU admissions may increase the risk of readmission. The development of intestinal obstruction syndrome should prompt urgent reoperation. Delayed presentation to the emergency department for abdominal pain may result in readmission. The presence of an enterocutaneous fistula does not increase the risk of readmission. The use of systemic steroids does not appear to be a risk factor for readmission. Preoperative prophylaxis by aminoglycosides and proton pump inhibitors may decrease the incidence of readmission. Longer periods of bowel rest do not reduce the risk of readmission. Proper patient education regarding postoperative care is essential for reducing the incidence of readmissions. Efforts aimed at improving patient outcomes through improved surgical technique and enhanced postoperative care will ultimately lead to reduced health-care expenses. Improved patient education and prophylaxis by aminoglycosides and proton pump inhibitors may help prevent readmissions after PD.
(1) The frequency of readmission after PD has been steadily increasing since 2002. (2) Patient age and sex are not risk factors for readmission after PD. (3) The need for blood transfusion does not appear to be associated with an increased risk of readmission. (4) Postoperative diarrhea is not a risk factor for readmission after PD. (5) The presence of an enterocutaneous fistula does not influence the risk of readmission. (6) The use of postoperative parenteral nutrition is not associated with an increased risk of readmission after PD. (7) The length of postoperative antibiotic therapy does not affect the risk of readmission. (8) Postoperative nausea and vomiting may not increase the risk of readmission after PD. (9) The use of proton pump inhibitors does not appear to be protective against readmission after PD. (10) The presence of a postoperative intra-abdominal abscess does not increase the risk of readmission after PD. (11) Length of hospital stay after PD does not influence the likelihood of readmission. (12) The use of prophylactic low-dose aspirin does not appear to decrease the incidence of readmission. (13) Early initiation of postoperative insulin therapy is not associated with a lower incidence of readmission after PD. (14) The presence of a postoperative perforated viscus does not increase the risk of readmission after PD. (15) Use of postoperative analgesia does not influence the risk of readmission after PD. (16) Patients who had a PD without a simultaneous pancreatectomy have a higher risk of read

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.2
Reasoning:
The assistant's reply contains a few correct points (it identifies pancreatic fistula, multivisceral/complex resection, prolonged initial stay and ICU admission as associated with readmission), but is largely inaccurate and internally inconsistent. It adds many unsupported or contradicted claims (prophylactic aminoglycosides and PPIs preventing readmission, absence of postoperative antibiotics as a risk factor, statements that length of stay does not influence readmission despite earlier saying the opposite, numerous numbered assertions that conflict with the cited study) and introduces details not present in the study. Crucially, it fails to emphasize the key conclusions: that complexity of the initial resection and pancreatic fistula were independent predictors and that about half of readmissions occur within 7 days, so efforts should target preventing early readmissions. Because of multiple factual errors, unsupported recommendations, and inconsistencies, the response is poor.

conciseness: 0.2
Reasoning:
The response is verbose, unfocused, and contains contradictory and unsupported statements; it does not concisely summarize the key findings (that pancreatic fistula and complexity of resection predict readmission and that half of readmissions occur early), instead listing many extraneous points and mixed conclusions. Overall it fails the conciseness criterion.

relevance: 0.2
Reasoning:
The assistant's reply is only partly relevant. It correctly identifies pancreatic fistula and multivisceral resection as risk factors (both present in the context), but it also introduces many unsupported or contradictory claims (for example, saying length of stay does not influence readmission despite the context reporting length of initial stay >7 days as an independent risk factor; asserting benefits or harms of antibiotics, aminoglycosides, PPIs, steroids, enterocutaneous fistula, and many other items that are not reported in the provided study). It also fails to highlight the key actionable point in the ground truth — that half of readmissions occur within 7 days and efforts should focus on preventing early readmissions. Overall the answer mixes a few correct points with multiple inaccuracies and extraneous, unsupported statements.

coherence: 0.2
Reasoning:
The response is poorly coherent and not well organized. It mixes some relevant points (pancreatic fistula and complex/multivisceral resection as risk factors) with many unsupported, contradictory, or irrelevant assertions (e.g., recommending aminoglycoside or PPI prophylaxis despite no evidence in the provided data; claiming both that antibiotic use is and is not a risk factor; claiming enterocutaneous fistula has no effect while earlier discussing fistula as a risk). The answer is repetitive, contains internal contradictions, includes numerous statements that are not grounded in the study context, and is cut off mid-sentence. It fails to highlight the principal, evidence-based conclusions (complexity of resection and pancreatic fistula independently predict readmission, and half of readmissions are early so prevention should focus there) in a clear, concise manner.

helpfulness: 0.3
Reasoning:
The response contains a few correct points (it correctly identifies pancreatic fistula and multivisceral resection as important predictors and notes an increasing readmission rate), but it is overall unreliable and inconsistent. It repeatedly makes unsupported or contradictory claims (eg, first saying prolonged initial stay and ICU admissions increase readmission risk, then later asserting length of stay does not influence readmission), recommends unverified prophylaxis (aminoglycosides, proton-pump inhibitors) not supported by the presented data, and lists many numbered statements that contradict the study findings or introduce facts not in the source. It also fails to emphasize the key ground-truth conclusion that half of readmissions are early (≤7 days) and that prevention efforts should focus on early readmissions. Due to these inaccuracies, contradictions, and unsupported recommendations, the answer is of low quality.

================================================================================
Average correctness Score: 0.5
Average conciseness Score: 0.495
Average relevance Score: 0.55
Average coherence Score: 0.555
Average helpfulness Score: 0.535
